Proteome Homeostasis Dysfunction: A Unifying Principle in ALS Pathogenesis - PubMed

Affiliations

• PMID: 32353332
• DOI: 10.1016/j.tins.2020.03.002

Review

Proteome Homeostasis Dysfunction: A Unifying Principle in ALS Pathogenesis

Justin J Yerbury et al. Trends Neurosci. 2020 May.

Abstract

Amyotrophic lateral sclerosis (ALS) is the most common motor neuron disease but currently has no effective treatment. Growing evidence suggests that proteome homeostasis underlies ALS pathogenesis. Protein production, trafficking, and degradation all shape the proteome. We present a hypothesis that proposes all genetic lesions associated with ALS (including in mRNA-binding proteins) cause widespread imbalance to an already metastable proteome. The impact of such dysfunction is felt across the entire proteome and is not restricted to a small subset of proteins. Proteome imbalance may cause functional defects, such as excitability alterations, and eventually cell death. While this idea is a unifying principle for all of ALS, we propose that stratification will appear that might dictate the efficacy of therapeutics based on the proteostasis network.

Keywords: metastability; misfolding; motor neuron disease; protein aggregation; proteome; proteostasis; ubiquitin.

Similar articles

• Proteostasis impairment and ALS.

  Lambert-Smith IA, Saunders DN, Yerbury JJ. Lambert-Smith IA, et al. Prog Biophys Mol Biol. 2022 Oct;174:3-27. doi: 10.1016/j.pbiomolbio.2022.06.001. Epub 2022 Jun 15. Prog Biophys Mol Biol. 2022. PMID: 35716729 Review.

• Vulnerability of the spinal motor neuron presynaptic terminal sub-proteome in ALS.

  Lum JS, Berg T, Chisholm CG, Vendruscolo M, Yerbury JJ. Lum JS, et al. Neurosci Lett. 2022 May 1;778:136614. doi: 10.1016/j.neulet.2022.136614. Epub 2022 Mar 31. Neurosci Lett. 2022. PMID: 35367314

• The metastability of the proteome of spinal motor neurons underlies their selective vulnerability in ALS.

  Yerbury JJ, Ooi L, Blair IP, Ciryam P, Dobson CM, Vendruscolo M. Yerbury JJ, et al. Neurosci Lett. 2019 Jun 21;704:89-94. doi: 10.1016/j.neulet.2019.04.001. Epub 2019 Apr 3. Neurosci Lett. 2019. PMID: 30953736

• Protein Homeostasis in Amyotrophic Lateral Sclerosis: Therapeutic Opportunities?

  Webster CP, Smith EF, Shaw PJ, De Vos KJ. Webster CP, et al. Front Mol Neurosci. 2017 May 2;10:123. doi: 10.3389/fnmol.2017.00123. eCollection 2017. Front Mol Neurosci. 2017. PMID: 28512398 Free PMC article. Review.

• Proteostasis disturbance in amyotrophic lateral sclerosis.

  Medinas DB, Valenzuela V, Hetz C. Medinas DB, et al. Hum Mol Genet. 2017 Oct 1;26(R2):R91-R104. doi: 10.1093/hmg/ddx274. Hum Mol Genet. 2017. PMID: 28977445 Review.

Cited by

• Duality of P2X7 Receptor in Amyotrophic Lateral Sclerosis.

  Volonté C, Amadio S, Liguori F, Fabbrizio P. Volonté C, et al. Front Pharmacol. 2020 Jul 24;11:1148. doi: 10.3389/fphar.2020.01148. eCollection 2020. Front Pharmacol. 2020. PMID: 32792962 Free PMC article. No abstract available.

• p62 overexpression induces TDP-43 cytoplasmic mislocalisation, aggregation and cleavage and neuronal death.

  Foster AD, Flynn LL, Cluning C, Cheng F, Davidson JM, Lee A, Polain N, Mejzini R, Farrawell N, Yerbury JJ, Layfield R, Akkari PA, Rea SL. Foster AD, et al. Sci Rep. 2021 Jun 1;11(1):11474. doi: 10.1038/s41598-021-90822-2. Sci Rep. 2021. PMID: 34075102 Free PMC article.

• Amyotrophic lateral sclerosis: a neurodegenerative disorder poised for successful therapeutic translation.

  Mead RJ, Shan N, Reiser HJ, Marshall F, Shaw PJ. Mead RJ, et al. Nat Rev Drug Discov. 2023 Mar;22(3):185-212. doi: 10.1038/s41573-022-00612-2. Epub 2022 Dec 21. Nat Rev Drug Discov. 2023. PMID: 36543887 Free PMC article. Review.

• Neuromuscular Junction Dysfunction in Amyotrophic Lateral Sclerosis.

  Verma S, Khurana S, Vats A, Sahu B, Ganguly NK, Chakraborti P, Gourie-Devi M, Taneja V. Verma S, et al. Mol Neurobiol. 2022 Mar;59(3):1502-1527. doi: 10.1007/s12035-021-02658-6. Epub 2022 Jan 8. Mol Neurobiol. 2022. PMID: 34997540 Review.

• Where and Why Modeling Amyotrophic Lateral Sclerosis.

  Liguori F, Amadio S, Volonté C. Liguori F, et al. Int J Mol Sci. 2021 Apr 12;22(8):3977. doi: 10.3390/ijms22083977. Int J Mol Sci. 2021. PMID: 33921446 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • ClinicalKey
  • Elsevier Science

• Medical

  • MedlinePlus Health Information

• Miscellaneous

  • NCI CPTAC Assay Portal